Department of Health, Taipei City Government

In response to the respiratory infection epidemic in China, the Taiwan Centers for Disease Control (CDC) has implemented “designated monitoring and encouraged testing” for symptomatic travelers entering from China, Hong Kong, and Macau at four international airports, since November 26, 2023. Mycoplasma pneumoniae had not been detected in the test results as of December 2. The general public should not be overly concerned, as this indicates that the domestic mycoplasma pneumoniae epidemic is low. According to the Department of Health, the Taiwan Food and Drug Administration (TFDA) has stated that domestic drugs for mycoplasma pneumoniae are sufficient. Additionally, anti-viral drugs for influenza COVID-19, as well as pandemic prevention material reserves, are in compliance with the safe stock levels. The public is reminded to complete vaccinations for influenza, streptococcus pneumonia, COVID-19, and other vaccinations before visiting China, Hong Kong, or Macau. Furthermore, the public is strongly advised to frequently wash their hands, wear face masks, and maintain personal hygiene in those areas. Symptomatic travelers are also encouraged to cooperate with the border testing measures implemented by the Taiwan CDC to aid early detection and treatment.

The Department of Health, Taipei City Government, explains that mycoplasma pneumoniae infection can occur at any time of year; however, it is more prevalent in the summer and autumn. All age groups are at risk of infection, but it is more common in young people and school-age children. Individuals recovering from other respiratory diseases or those with weakened immune systems are at a higher risk of severe infection. Mycoplasma pneumoniae is spread by droplets from coughing or sneezing; symptoms are mild after infection, and recovery can take one to four weeks. Clinical symptoms include sore throat, fatigue, fever, and a cough that lasts for weeks or even months; however, about 10% of patients also develop pneumonia, which can be effectively treated with antibiotics under medical guidance.

There is currently no shortage of mycoplasma pneumoniae medication for children and adults. According to “The drug supply management system (DSMS)” of the Taiwan Food and Drug Administration (TFDA) there are two drug permits about Azithromycin suspension powder for pediatric use. “Zithromax Powder for Oral Suspension 47.78mg/gm and Azithrom susp. 47.78mg/gm,” which are both in stable supply.

The World Health Organization (WHO) has recently reported that, in addition to the declining mycoplasma pneumoniae epidemic, there are also diseases that cause respiratory infection in China, such as influenza, Respiratory Syncytical Virus (RSV), adenovirus, and others. Autumn and winter are prime months for the emergence of infectious diseases of the respiratory tract. Department of Health, Taipei City Government recommends that the public implement five major pandemic prevention measures:

1. Stay Safe, vaccinate promptly: Timely complete vaccinations for influenza, streptococcus pneumococcal pneumonia, COVID-19, and other recommended vaccines.
2. Personal hygiene and frequent handwashing: Pay attention to personal hygiene and be sure to wash hands frequently and wear masks.
3. Don't self-medicate if symptomatic: In case of fever or acute respiratory symptoms, refrain from self-administering antibiotics. Seek prompt medical attention and follow the prescribed treatment.
4. Inform about travel history when seeking medical attention: When visiting a healthcare professional, proactively provide information about travel history, occupation, contact history, and cluster situations (TOCC).
5. Implement self-quarantine measures: Adhere to self-quarantine measures, such as staying home and avoiding work or school when experiencing symptoms.

The Department of Health, Taipei City Government urges individuals in high-risk groups to promptly get vaccinated for free influenza. Those who have not yet received the COVID-19 XBB.1.5 vaccine are also encouraged to get vaccinated simultaneously. reducing the risk of severe illness and death.